New targets in the search for preventive and therapeutic agents for botulism

Expert Rev Anti Infect Ther. 2014 Sep;12(9):1075-86. doi: 10.1586/14787210.2014.945917. Epub 2014 Aug 4.

Abstract

Botulism is a severe neuroparalytic disease resulting from exposure to one of the most poisonous toxins to humans. Because of this high potency and the use of toxins as biological weapons, botulism is a public health concern and each case represents an emergency. Current therapy involves respiratory supportive care and anti-toxins administration. As a preventive measure, vaccination against toxins represents an effective strategy but is undesirable due the rarity of botulism and the effectiveness of toxins in treating several neuromuscular disorders. This paper summarizes the current issues in botulism treatment and prevention, highlighting the challenge for future researches.

Keywords: bacteriocins; botulinum toxin; botulism; inhibitors; microbial antagonism; prevention; therapy; vaccine.

Publication types

  • Review

MeSH terms

  • Bacterial Vaccines / immunology*
  • Botulinum Antitoxin / administration & dosage
  • Botulinum Antitoxin / therapeutic use*
  • Botulinum Toxins / antagonists & inhibitors
  • Botulinum Toxins / immunology
  • Botulism / drug therapy*
  • Botulism / immunology
  • Botulism / microbiology
  • Botulism / prevention & control*
  • Clostridium botulinum / drug effects
  • Clostridium botulinum / immunology
  • Drug Discovery*
  • Humans
  • Vaccines, Synthetic / immunology

Substances

  • Bacterial Vaccines
  • Botulinum Antitoxin
  • Vaccines, Synthetic
  • Botulinum Toxins